83
Participants
Start Date
June 30, 2015
Primary Completion Date
June 17, 2020
Study Completion Date
December 16, 2021
VRC01
Administered by subcutaneous injection in the thigh
VRC01LS
Administered by subcutaneous injection in the thigh
VRC07-523LS
Administered by subcutaneous injection in the thigh
Famcru Crs, Tygerberg
Bronx-Lebanon Hospital Center NICHD CRS, The Bronx
Jacobi Med. Ctr. Bronx NICHD CRS, The Bronx
Johns Hopkins Univ. Baltimore NICHD CRS, Baltimore
Emory University School of Medicine NICHD CRS, Atlanta
Univ. of Florida Jacksonville NICHD CRS, Jacksonville
Pediatric Perinatal HIV Clinical Trials Unit CRS, Miami
South Florida CDTC Ft Lauderdale NICHD CRS, Fort Lauderdale
Univ. of Colorado Denver NICHD CRS, Aurora
David Geffen School of Medicine at UCLA NICHD CRS, Los Angeles
Texas Children's Hospital CRS, Houston
San Juan City Hosp. PR NICHD CRS, San Juan
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS, San Juan
Harare Family Care CRS, Harare
National Institute of Allergy and Infectious Diseases (NIAID)
NIH